Conflicts of interest: None.
The role of the human papillomavirus (HPV) vaccine in developing countries
Version of Record online: 15 MAR 2010
© 2010 The International Society of Dermatology
International Journal of Dermatology
Volume 49, Issue 4, pages 377–379, April 2010
How to Cite
Kling, M. and Zeichner, J. A. (2010), The role of the human papillomavirus (HPV) vaccine in developing countries. International Journal of Dermatology, 49: 377–379. doi: 10.1111/j.1365-4632.2010.04316.x
- Issue online: 15 MAR 2010
- Version of Record online: 15 MAR 2010
- 1The potential public health impact of vaccines against human papillomavirus. In: PrendivillW, DaviesP, eds. The Clinical Handbook of Human Papillomavirus. Lancaster, United Kingdom: Parthenon Publishing/Parthenon Medical Communications, 2004., .
- 2World Health Organization (WHO) Projects of mortality and burden of disease. Accessed March 15, 2009. http://www.who.int/healthinfo/global_burden_disease/en/index.htm.
- 5Infections Causing Human Cancer. Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2006: 1–16..
- 6Discovery of AIDS and cancer viruses win Nobel. NY Times October 7, 2008.
- 10Coverage of cervical cancer screening in 57 countries: low average level and large inequalities. Policy Forum 2008 Accessed: March 15, 2009., , .
- 12Prescribing Information. Whitehouse Station, NJ: Merck and Co, Inc., 2006..
- 15GAVI The global alliance for vaccines and immunization. Accessed March 15, 2009. http://www.gavialliance.org.
- 20News Network of the United Nations and the International Community GAVI alliance: new vaccine strategy prioritises deadly diseases meningococcal Japanese encephalitis and cervical cancer among those identified. Accessed March 15, 2009. http://www.maximsnews.com/news20080718gaviallncevaccinationprioritisation10807181604.htm.